Hee Chul Han Selected Research

Hee Chul Han Research Topics

Disease

15	Pain (Aches) 01/2022 - 03/2002
3	Hyperalgesia 01/2014 - 04/2007
2	Osteoarthritis 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 04/2007
2	Hypertension (High Blood Pressure) 01/2021 - 12/2013
2	Arthritis (Polyarthritis) 01/2020 - 01/2016
1	Intervertebral Disc Degeneration 01/2022
1	Colitis 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Obesity 10/2020
1	Metabolic Diseases (Metabolic Disease) 10/2020
1	Alcoholic Fatty Liver 10/2020
1	Non-alcoholic Fatty Liver Disease 10/2020
1	Muscular Atrophy (Muscle Atrophy) 01/2019
1	Hyperglycemia 01/2018
1	Diabetes Mellitus 01/2018
1	Constipation 10/2016
1	Pruritus (Itching) 10/2016
1	Stroke (Strokes) 09/2014
1	Neuralgia (Stump Neuralgia) 01/2014
1	Arthralgia (Joint Pain) 07/2004

Drug/Important Bio-Agent (IBA)

7	CarrageenanIBA 01/2020 - 11/2003
3	Arginine Vasopressin (Argipressin)IBA 01/2021 - 12/2013
3	Analgesics (Analgesic Drugs)IBA 01/2021 - 07/2004
3	SaltsIBA 01/2021 - 12/2013
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2009 - 11/2003
2	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 06/2009
2	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2021 - 12/2013
2	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2021 - 01/2021
2	Acetates (Acetic Acid Esters)FDA Link 01/2021 - 12/2013
2	SodiumIBA 01/2021 - 12/2013
2	Coloring Agents (Dyes)IBA 01/2021 - 01/2021
2	CytokinesIBA 01/2020 - 01/2016
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2019 - 04/2007
1	Iodoacetic AcidIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Choline (Choline Chloride)IBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	ClusterinIBA 10/2020
1	Methionine (L-Methionine)FDA Link 10/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Freund's AdjuvantIBA 01/2019
1	ORALIT (ORS)IBA 10/2016
1	Opioid Receptors (Opioid Receptor)IBA 10/2016
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 10/2016
1	Volatile Oils (Essential Oils)IBA 01/2016
1	Mineral Oil (Liquid Paraffin)FDA LinkGeneric 01/2016
1	Therapeutic UsesIBA 09/2014
1	salicylhydroxamic acid (SHAM)IBA 01/2014
1	GABA-A Receptors (GABA(A) Receptor)IBA 12/2013
1	gamma-Aminobutyric Acid (GABA)IBA 12/2013
1	Vasopressins (Vasopressin)IBA 12/2013
1	Bumetanide (Bumex)FDA LinkGeneric 12/2013
1	2-amino-4-phosphono-propinateIBA 05/2013
1	Naloxone (Narcan)FDA LinkGeneric 06/2009
1	Opioid Analgesics (Opioids)IBA 06/2009
1	metabotropic glutamate receptor type 1IBA 04/2007
1	Halothane (Fluothane)FDA Link 10/2006
1	Ketamine FDA LinkGeneric 07/2004
1	Memantine (Namenda)FDA Link 07/2004
1	Dizocilpine Maleate (Dizocilpine)IBA 11/2003
1	QuinoxalinesIBA 11/2003
1	N-Methylaspartate (NMDA)IBA 11/2003
1	2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA 11/2003
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 03/2002

Therapy/Procedure

2	Therapeutics 10/2016 - 09/2014
2	Intra-Articular Injections 07/2004 - 11/2003
1	Denervation 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Injections 01/2020
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2014
1	Ligation 01/2014
1	Anesthesia 10/2006
1	Electroacupuncture 10/2006
1	Analgesia 07/2004